NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
Academic and Community Cancer Research United
Shiraz University of Medical Sciences
University Magna Graecia
University of Sao Paulo
Office of Rare Diseases (ORD)